Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ACVR1C Monoclonal Antibody (118311)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA523803
Description
In Western blots, no cross-reactivity with recombinant human Activin R1B is observed. Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
ACVR1C, a serine/threonine protein kinase, is a type I receptor for the TGFB family of signaling molecules. The receptor complex consisting of 2 type II and 2 type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators, SMAD2 and SMAD3, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors. ACVR1C is a receptor for activin AB, activin B and NODAL. This protein plays a role in cell differentiation, growth arrest and apoptosis.
Specifications
ACVR1C | |
Monoclonal | |
0.5 mg/mL | |
PBS with 5% trehalose and No Preservative | |
P70539 | |
ACVR1C | |
Mouse myeloma cell line NS0-derived recombinant rat ALK-7 Leu26-Arg108. | |
100 μg | |
Primary | |
Rat | |
Antibody | |
IgG2a |
Flow Cytometry, Western Blot | |
118311 | |
Unconjugated | |
ACVR1C | |
activin A receptor type 1C; activin A receptor type IC; activin A receptor, type IC; activin receptor type IC; Activin receptor type-1C; activin receptor-like kinase 7; ACTRI; ACTR-IC; ACVR1A; acvr1c; acvr1c {ECO:0000312; ACVRLK2; ACVRLK7; ALK2; Alk7; ALK-7; C230097P10; EMBL:AAC52803.1}; FOP; habrec1; SKR1; TGF-beta type 1 receptor; TSRI | |
Mouse | |
Protein A/G | |
RUO | |
245921 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction